The Georgian pharmaceutical company "Neopharm" successfully passed the GDP (Good Distribution Practice) inspection and received the relevant standard certificate.
GDP is a globally recognized standard that helps pharmaceutical companies ensure the safe supply of medicines to the market.
A quality management system has been implemented in the "Neopharm" company, which ensures the supply of quality, effective and safe medicines at all stages of the distribution chain.
The pharmaceutical company "Neopharm" was founded in 1997 and has been part of the country's healthcare system for 25 years. The product portfolio consists of innovative, original prescription medicinal products, mostly made from herbal raw materials. Special technology ensures that the active pharmaceutical ingredient is obtained from plant raw materials in its natural state, which leads to the high efficiency of the final product and fewer side effects compared to synthetic substances.
Today, the company serially manufactures more than 100 products, including tinctures, extracts, syrups, herbal oils, capsules, tablets, ointments, eye drops, herbal substances, and cosmetics.